SARS-CoV-2: vaccines in the pandemic era

Area of Science:

• Immunology
• Virology
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths globally.
• Limited natural immunity and lack of specific antiviral drugs necessitate rapid vaccine development.

Purpose of the Study:

• To review the progress of COVID-19 vaccine development.
• To summarize findings from animal experiments and clinical trials for various vaccine platforms.
• To discuss challenges in vaccine development, evaluation, and application.

Main Methods:

• Literature review of published animal experiments and clinical trials.
• Analysis of data from diverse vaccine technical platforms.
• Discussion of challenges encountered during the pandemic.

Main Results:

• Multiple vaccine technical platforms are under investigation for COVID-19.
• Promising results have emerged from preclinical and clinical studies.
• Significant challenges remain in vaccine deployment and efficacy.

Conclusions:

• Accelerated vaccine development is crucial to control the COVID-19 pandemic.
• Continued research and collaboration are needed to overcome existing challenges.
• Effective vaccine strategies are essential for global public health recovery.